Skip to content

CATALYST PHARMACEUTICALS, INC.

CPRX

CIK 0001369568

← back to feed
Revenue (TTM)
$585.77M
+19.8% YoY Q1 May 2026
Net Income (TTM)
$225.36M
+30.8% YoY Q1 May 2026
EPS Diluted (TTM)
$1.78
+28.2% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
46.0%
Q1 May 2026
Net Margin
38.5%
Q1 May 2026
Free Cash Flow (TTM)
$163.33M
Q1 May 2026
Cash
$755.86M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
122.38M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings